Andy Pasternak - 01 Nov 2021 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role: EVP and Chief Business Officer
Signature: /s/ Miles W. McHugh, Attorney-in-Fact
Issuer symbol: HZNP
Transactions as of: 01 Nov 2021
Net transactions value: -$650,950
Form type: 4
Filing time: 03 Nov 2021, 16:31:47 UTC
Previous filing: 13 Sep 2021
Next filing: 05 Nov 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HZNP	Ordinary Shares	Options Exercise		+12,421	+53%		35,775	01 Nov 2021	Direct	F1
transaction	HZNP	Ordinary Shares	Tax liability	$650,950	-5,503	-15%	$118.29	30,272	01 Nov 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HZNP	Restricted Stock Units	Options Exercise	$0	+12,421		$0.000000	12,421	01 Nov 2021	Ordinary shares	12,421		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer.
F2	The shares subject to the restricted stock units vest in three equal annual installments, beginning November 1, 2020.